Roche Holding Ltd. (ROG) Given a CHF 215 Price Target by HSBC Holdings plc Analysts
Roche Holding Ltd. (VTX:ROG) has been given a CHF 215 target price by research analysts at HSBC Holdings plc in a note issued to investors on Tuesday. The firm presently has a “sell” rating on the healthcare company’s stock.
A number of other research firms have also recently commented on ROG. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on shares of Roche Holding and gave the stock a “buy” rating in a research note on Tuesday, June 6th. Jefferies Group LLC set a CHF 305 price objective on shares of Roche Holding and gave the company a “buy” rating in a report on Monday, May 29th. Morgan Stanley set a CHF 290 price objective on shares of Roche Holding and gave the company a “buy” rating in a report on Monday, May 29th. J P Morgan Chase & Co reiterated a “buy” rating on shares of Roche Holding in a report on Saturday, May 20th. Finally, Barclays PLC set a CHF 320 price objective on shares of Roche Holding and gave the company a “buy” rating in a report on Saturday, May 20th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of CHF 273.64.
Roche Holding (VTX:ROG) opened at 243.40 on Tuesday. The stock’s 50 day moving average is CHK 259.00 and its 200 day moving average is CHK 249.75. The company has a market capitalization of CHK 207.37 billion and a P/E ratio of 20.89. Roche Holding has a 52 week low of CHK 218.30 and a 52 week high of CHK 273.00.
COPYRIGHT VIOLATION WARNING: “Roche Holding Ltd. (ROG) Given a CHF 215 Price Target by HSBC Holdings plc Analysts” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/07/13/roche-holding-ltd-rog-given-a-chf-215-price-target-by-hsbc-holdings-plc-analysts.html.
About Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.